Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study - ScienceDirect
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Landmark Trials in Anemia & Kidney Disease - Renal Fellow Network
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) | SpringerLink
Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Anemia management: a historical perspective - Kidney International Supplements
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis | Aging
IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis | NEJM
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
HIF Stabilizers Get in Sync: Are ESAs Bye Bye Bye? in: Kidney News Volume 13 Issue 3 (2021)
Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Iron metabolism and management: focus on chronic kidney disease - Kidney International Supplements
Roxadustat for CKD-related Anemia in Non-dialysis Patients - ScienceDirect
Drug trial shows efficacy in treating anemia in chronic kidney disease patients without dialysis
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis - ScienceDirect
Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation | Arteriosclerosis, Thrombosis, and Vascular Biology
Treatment of anemia in difficult-to-manage patients with chronic kidney disease - Kidney International Supplements
Roxadustat | PDF | Chronic Kidney Disease | Anemia
JCM | Free Full-Text | Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
